Cannabis and Dronabinol
Browse the latest research linking medical marijuana / medicinal cannabis and Dronabinol.
(cannabinoid (synthetic)) Dronabinol, sold as trade names Marinol and Syndros, is an appetite stimulant, antiemetic, and sleep apnea reliever. [Wikipedia]
Click on a study title below to open a new tab with full article, or click on a compound to see it's full list of research.
Compounds Topics Title Date
cannabis,Dronabinol gastroparesis via survey (n=197) Cannabinoid Use in Patients With Gastroparesis and Related Disorders Mar 2019
A third of patients with Gp symptoms actively use cannabinoids for their chronic symptoms. Most of these patients perceive improvement in their symptoms with cannabinoids.
Nabilone,Dronabinol cud in humans via placebo trial (n=14) Subjective, cognitive, and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers Jan 2012
Ingestion Method: nabilone (2, 4, 6, 8 mg), dronabinol (10, 20 mg)
Nabilone (4, 6, 8 mg) and dronabinol (10, 20 mg) increased ratings of feeling a good effect, a strong effect, and/or `high' relative to placebo; nabilone had a slower onset of peak subjective effects than dronabinol. Nabilone (6, 8 mg) modestly lowered psychomotor speed relative to placebo and dronabinol.
Dronabinol appetite boost,hiv in humans via trial (n=139) Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Feb 1995
Positive  Dronabinol was found to be safe and effective for anorexia associated with weight loss in patients with AIDS.
Dronabinol appetite boost,sleep,cancer in humans via placebo trial (n=47/65) Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. Sep 2011
Positive  THC-treated patients reported improved (P = 0.026) and enhanced (P < 0.001) chemosensory perception and food 'tasted better' (P = 0.04). Premeal appetite (P = 0.05) and proportion of calories consumed as protein increased compared with placebo (P = 0.008). THC-treated patients reported increased quality of sleep (P = 0.025) and relaxation (P = 0.045).